These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15600266)

  • 1. Altered renal function in normoalbuminuric type 2 diabetes.
    Futrakul N; Vongthavarawat V; Chairatanarat T; Sirisalipotch S; Futrakul P; Suwanwalaikorn S
    Ren Fail; 2004 Nov; 26(6):727-8. PubMed ID: 15600266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes.
    Futrakul N; Vongthavarawat V; Sirisalipotch S; Chairatanarat T; Futrakul P; Suwanwalaikorn S
    Clin Hemorheol Microcirc; 2005; 32(1):59-65. PubMed ID: 15665427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.
    Dalla Vestra M; Mussap M; Gallina P; Bruseghin M; Cernigoi AM; Saller A; Plebani M; Fioretto P
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S78-82. PubMed ID: 15938041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural history of diabetic nephropathy].
    Ishimura E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():324-30. PubMed ID: 15999728
    [No Abstract]   [Full Text] [Related]  

  • 7. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normoalbuminuric diabetic kidney disease.
    Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L
    Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuria and glomerular filtration rate in type 2 diabetes mellitus.
    Magri CJ; Fava S
    Minerva Urol Nefrol; 2011 Dec; 63(4):273-80. PubMed ID: 21996982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M; Gross JL; Silveiro SP
    J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal functional reserve in patients with recently diagnosed Type 2 diabetes mellitus with and without microalbuminuria.
    Guízar JM; Kornhauser C; Malacara JM; Amador N; Barrera JA; Esparza R
    Nephron; 2001 Mar; 87(3):223-30. PubMed ID: 11287757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unrecognized prevalence of chronic kidney disease in diabetes.
    Middleton RJ; Foley RN; Hegarty J; Cheung CM; McElduff P; Gibson JM; Kalra PA; O'Donoghue DJ; New JP
    Nephrol Dial Transplant; 2006 Jan; 21(1):88-92. PubMed ID: 16221715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of albuminuria and renal disease in diabetes mellitus.
    Sale MM; Freedman BI
    Nephrol Dial Transplant; 2006 Jan; 21(1):13-6. PubMed ID: 16234290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Developmental phases and diagnostic criteria in diabetic nephropathy].
    Duława J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):807-9. PubMed ID: 2096373
    [No Abstract]   [Full Text] [Related]  

  • 18. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
    Steinke JM; Sinaiko AR; Kramer MS; Suissa S; Chavers BM; Mauer M;
    Diabetes; 2005 Jul; 54(7):2164-71. PubMed ID: 15983218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of albuminuria in diabetic nephropathy.
    Wada T; Shimizu M; Toyama T; Hara A; Kaneko S; Furuichi K
    Clin Exp Nephrol; 2012 Feb; 16(1):96-101. PubMed ID: 21830044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.